1.Vogt-Koyanagi-Harada disease in an 8-year-old boy
Budi SETIABUDIAWAN ; Feti KARFIATI ; Reni GHRAHANI ; Gartika SAPARTINI ; Indra SAHRIL
Asia Pacific Allergy 2011;1(2):98-103
Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disease involving pigmented tissue in eyes, auditory system, skin, and central nervous system. The pathogenesis is a result of T cell lymphocyte reaction against melanocyte component, tyrosinase and tyrosinase-related protein. This disease uniquely affected pigmented race in Asia and native America, mostly women aged 20-50. We reported an 8-years-old boy complained for visual disturbance since 6 weeks prior admission. Two years earlier, the parents noted the patient eyes were looked red when photographed (suggesting a dilated pupil) preceded by whitened on the right forehead and nose and whitened hair, eyebrow and eyelashes. The examination showed a vitiligo and skin atrophy on right frontal and right nasal, poliosis on the eyebrows, eyelids and hair. The diameter of right pupil was 8 mm, with a paresis on 3rd, 4th, 6th, and 9th nerves. Fundus examination revealed sunset glow appearance. The visual acuity on the right eye: 2/60, left eye: 1-0. There's positive serology for antitoxoplasma IgG, anti Rubella IgG, anti CMV IgG. The patient was diagnosed with a VKH disease and then prescribed with methylprednisolone 1 mg/kg/day. The patient also had further follow up with dermatovenerologist and ophthalmologist. The eye examination revealed an improvement on right eye panuveitis, with a remaining keratic precipitate in the endothelium, and minimal flare and cell on the anterior chamber. ENT consultation revealed no ear inflammation or hearing disturbance.
Americas
;
Anterior Chamber
;
Asia
;
Atrophy
;
Autoimmune Diseases
;
Central Nervous System
;
Child
;
Continental Population Groups
;
Endothelium
;
Eyebrows
;
Eyelashes
;
Eyelids
;
Female
;
Follow-Up Studies
;
Forehead
;
Hair
;
Hearing
;
Humans
;
Immunoglobulin G
;
Lymphocytes
;
Male
;
Melanocytes
;
Methylprednisolone
;
Monophenol Monooxygenase
;
Nose
;
Otitis
;
Panuveitis
;
Parents
;
Paresis
;
Pupil
;
Rubella
;
Skin
;
Uveomeningoencephalitic Syndrome
;
Visual Acuity
;
Vitiligo
2.Age of onset as a risk factor of renal involvement in Henoch-Schönlein purpura
Reni GHRAHANI ; Masayu Amanda LEDIKA ; Gartika SAPARTINI ; Budi SETIABUDIAWAN
Asia Pacific Allergy 2014;4(1):42-47
BACKGROUND: Henoch-Schönlein purpura (HSP) is the most common vasculitis in children, characterized by triad of symptoms; palpable purpura without thrombocytopenia, abdominal pain, and arthritis. Renal involvement often occur in children with HSP. No data on the renal involvement of children with HSP in Indonesia, especially West Java. OBJECTIVE: To evaluate renal involvement in children with HSP. METHODS: Retrospective study was conducted in children with HSP in Department of Child Health, Hasan Sadikin Hospital, from 2006 to 2011. Characteristics and clinical manifestations was reviewed from medical record. HSP was diagnosed by American College of Rheumatology 1990 criteria or European League Against Rheumatism/Pediatric Rheumatology International Trials Organization/Pediatric Rheumatology European Society 2008. RESULTS: There were 128 patients, consisting of 82 male (64.9%) and 46 female (35.1%) with ratio 1.8:1. Mean age was 7.9 ± 2.9 years old which range from 6 month to 15 years. Peak morbidity was between 5-10 years old. Prevalence of HSP in Hasan Sadikin Hospital tend to raise from 2.7/100,000 in 2008 to 5.2/100,000 in 2010. In most patients (71%) purpura was the first symptom. Seventy-one patients (44.5%) had arthritis and 89 patients (69.5%) had abdominal pain, while renal involvement was in 28 patients (21.8%). Gastrointestinal manifestations tend to manifest in patients less than 5 years old (p = 0.267), while renal involvement tend to manifest in age group 11-15 years old (p = 0.015) with odds ratio 3.1 (95% confidence interval, 1.2-8.1). CONCLUSION: Renal involvement in children with HSP is more common in age group 11 to 15 years old.
Abdominal Pain
;
Age of Onset
;
Arthritis
;
Child
;
Child Health
;
Female
;
Humans
;
Indonesia
;
Male
;
Medical Records
;
Odds Ratio
;
Prevalence
;
Purpura
;
Purpura, Schoenlein-Henoch
;
Retrospective Studies
;
Rheumatology
;
Risk Factors
;
Thrombocytopenia
;
Vasculitis
3.Growth Patterns of Indonesian Infants with Cow's Milk Allergy and Fed with Soy-Based Infant Formula
Budi SETIABUDIAWAN ; Mei Neni SITARESMI ; Gartika SAPARTINI ; Sumadiono ; Endah CITRARESMI ; Rini SEKARTINI ; Azwin Mengindra PUTRA ; Juandy JO
Pediatric Gastroenterology, Hepatology & Nutrition 2021;24(3):316-324
Purpose:
The use of soy-based infant formula has increased widely in infants with cow's milk allergy (CMA). This study aimed to provide evidence on the growth pattern of CMA infants fed with soy-based infant formula in an Indonesian setting.
Methods:
A multi-site, intervention study was conducted among full-term and normal birth weight CMA infants. Within six months, the subjects were provided with a soy-based infant formula. Weight, height, and head circumference were measured at baseline, weeks 4, 8, 12, 16, 20, and 24. Adverse events were recorded by scoring atopic dermatitis and symptombased clinical scores.
Results:
Based on the World Health Organization growth chart, we found that most of subjects had normal nutritional status for weight-for-age, length-for-age, weight-for-length, and head-circumference-for-age. There were statistically significant differences between baseline and end-line for weight-for-age, length-for-age, weight-for-length, and head circumference-for-age nutritional status. No allergic symptoms or intolerance toward soy formula were observed at the end of the intervention period.
Conclusion
These results show that infants fed with soy-based infant formula have a normal pattern of growth.
4.Growth Patterns of Indonesian Infants with Cow's Milk Allergy and Fed with Soy-Based Infant Formula
Budi SETIABUDIAWAN ; Mei Neni SITARESMI ; Gartika SAPARTINI ; Sumadiono ; Endah CITRARESMI ; Rini SEKARTINI ; Azwin Mengindra PUTRA ; Juandy JO
Pediatric Gastroenterology, Hepatology & Nutrition 2021;24(3):316-324
Purpose:
The use of soy-based infant formula has increased widely in infants with cow's milk allergy (CMA). This study aimed to provide evidence on the growth pattern of CMA infants fed with soy-based infant formula in an Indonesian setting.
Methods:
A multi-site, intervention study was conducted among full-term and normal birth weight CMA infants. Within six months, the subjects were provided with a soy-based infant formula. Weight, height, and head circumference were measured at baseline, weeks 4, 8, 12, 16, 20, and 24. Adverse events were recorded by scoring atopic dermatitis and symptombased clinical scores.
Results:
Based on the World Health Organization growth chart, we found that most of subjects had normal nutritional status for weight-for-age, length-for-age, weight-for-length, and head-circumference-for-age. There were statistically significant differences between baseline and end-line for weight-for-age, length-for-age, weight-for-length, and head circumference-for-age nutritional status. No allergic symptoms or intolerance toward soy formula were observed at the end of the intervention period.
Conclusion
These results show that infants fed with soy-based infant formula have a normal pattern of growth.